← Yangiliklar markaziga qaytish
Sog‘liq
FDA Approves First Drug Shown to Help Patients with Infantile-Onset Niemann-Pick Disease Type C Live Longer
Manba: U.S. Food and Drug Administration (FDA)
E’lon qilingan:
Tarjima qilinmagan — asl tilda ko‘rsatilgan (ingliz tili).
Manba bergan mazmun — U.S. Food and Drug Administration (FDA)
FDA approved Lembaz (adrabetadex) injection, the first treatment shown to help people with a severe form of Niemann-Pick disease type C (NPC) live longer.
Bu sahifada nashriyot bildirgan ma’lumot keltirilgan. MYITEDU bu da’volarni mustaqil tekshirmagan.
Asl maqolani o‘qish — U.S. Food and Drug Administration (FDA) ↗
Manba ko‘rsatilishi: Source: U.S. Food and Drug Administration (fda.gov)
Ulashish
Instagram saytlardan havola ulashishni qo‘llab-quvvatlamaydi. Kartani yuklab oling, Instagram ilovasida joylang va izohni qo‘ying.
Tuzatish haqida xabar berish
Materialdagi, tarjimadagi, sanadagi yoki manba ko‘rsatilishidagi xato haqida xabar bering. Aloqa ma’lumotlaringiz maxfiy saqlanadi va faqat javob berish uchun ishlatiladi.